Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMLVMJH)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
1,3-Dicyclohexylurea; n,n'-dicyclohexylurea; 2387-23-7; Dicyclohexylurea; Urea, N,N'-dicyclohexyl-; UNII-ZV7823VVIM; ZV7823VVIM; CHEMBL1458; N,N'-Dicyclohexylurea, 98%; ADFXKUOMJKEIND-UHFFFAOYSA-N; MFCD00003829; Urea,3-dicyclohexyl-; Urea,N'-dicyclohexyl-; N,N inverted exclamation marka-Dicyclohexylurea; Urea, 1,3-dicyclohexyl-; dicylohexylurea; dicylcohexylurea; dicylohexyl urea; dicyclohexyl-urea; dicyclohexyl urea; DCW; EINECS 219-213-7; NSC 30023; NSC 17013; n.n'-dicyclohexylurea; Rupatadine Impurity 1; 1,3-dicyclohexyl-urea
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
||||||||||||||||
|
||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Breast
Breast adenocarcinoma
Colon
Colorectal adenocarcinoma
Hematopoietic system
Normal
Kidney
Normal (Immortalized)
Liver
Hepatoblastoma
Lung
Lung adenocarcinoma
Non-small cell lung carcinoma
Prostate
Prostate carcinoma
Skin
Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
